A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma

External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry

(2017) Sophie E. M. Veldhuijzen van Zanten et al.   JOURNAL OF NEURO-ONCOLOGY

Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas

(2016) T. Jaspan et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Gemcitabine Plus Radiation Therapy for High-Grade Glioma: Long-Term Results of a Phase 1 Dose-Escalation Study

(2016) Michelle M. Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature

(2016) Sophie E. M. Veldhuijzen van Zanten et al.   JOURNAL OF NEURO-ONCOLOGY

Children with minimal chance for cure: parent proxy of the child’s health-related quality of life and the effect on parental physical and mental health during treatment

(2016) Belinda N. Mandrell et al.   JOURNAL OF NEURO-ONCOLOGY

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands

(2014) Sophie EM Veldhuijzen van Zanten et al.   Expert Review of Anticancer Therapy

Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria

(2014) Marc H. Jansen et al.   NEURO-ONCOLOGY

Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology

(2011) M.H.A. Jansen et al.   CANCER TREATMENT REVIEWS

Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

(2009) Giulio Metro et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report

(2009) Peter D. Cole et al.   JOURNAL OF CLINICAL ONCOLOGY

Dose Escalation Methods in Phase I Cancer Clinical Trials

(2009) Christophe Le Tourneau et al.   JNCI-Journal of the National Cancer Institute

Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer

(2008) J. Sigmond et al.   ANNALS OF ONCOLOGY